FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/02/049542 [Registered on: 08/02/2023] Trial Registered Prospectively
Last Modified On: 07/02/2023
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Using the value of red blood cell distribution and dividing it by blood level of calcium in people with recent pancreas disease to obtain a value to see how fast the disease worsens and causes death. 
Scientific Title of Study   Red Cell Distribution Width to Serum Calcium ratio as a predictor of severity and mortality of acute pancreatitis 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Varsha Janakiramanan 
Designation  Junior Resident 
Affiliation  Kasturba Medical College Manipal, Manipal Academy of Higher Education (MAHE) 
Address  Department of General Medicine, Kasturba Medical College, Manipal, Karnataka

Udupi
KARNATAKA
576104
India 
Phone  9108768709  
Fax    
Email  varshajr@rocketmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Weena Stanley 
Designation  Professor and Unit Chief 
Affiliation  Kasturba Medical College Manipal, Manipal Academy of Higher Education (MAHE) 
Address  Department of General Medicine, Kasturba Medical College, Manipal, Karnataka

Udupi
KARNATAKA
576104
India 
Phone  9844111974  
Fax    
Email  weena.stanley@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Varsha Janakiramanan 
Designation  Junior Resident 
Affiliation  Kasturba Medical College Manipal, Manipal Academy of Higher Education (MAHE) 
Address  Department of General Medicine, Kasturba Medical College, Manipal, Karnataka

Udupi
KARNATAKA
576104
India 
Phone  9108768709  
Fax    
Email  varshajr@rocketmail.com  
 
Source of Monetary or Material Support  
Kasturba Medical college, Manipal 
 
Primary Sponsor  
Name  Varsha Janakiramanan 
Address  Department Of General Medicine, KMC Manipal, Karnataka 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Varsha Janakiramanan  Kasturba Hospital, Manipal  Department Of General Medicine,Room 6, Kasturba Medical College, Manipal, Madhav Nagar, Udupi,Karnataka
Udupi
KARNATAKA 
9108768709

varshajr@rocketmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
KH and KMC institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K859||Acute pancreatitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1. > 18 years old
2.Diagnosed as acute pancreatitis based on:

1.Clinical presentation with acute persistent abdominal pain
2.Serum amylase exceeding 3 times the upper limit of normal (100 IU/L)
3.Characteristic findings on abdominal ultrasonography and/or computed
tomography

At least 2/3 
 
ExclusionCriteria 
Details  1. Acute coronary syndrome
2. Congestive cardiac failure
3. Acute pulmonary embolism
4. Cerebrovascular accident
5. Malignancy
6. Chronic kidney disease
7. Chronic liver disease
8. Recent transfusion history
9. Pregnancy
10. Trauma
11. Anemia (Hb <10g/dl) 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To predict the severity and mortality in patients with acute pancreatitis using RDW to serum
calcium ratio. 
February 2024 to July 2024 
 
Secondary Outcome  
Outcome  TimePoints 
To prognosticate the severity and mortality of acute pancreatitis with the BISAP score (Blood urea nitrogen, Impaired
mental status, SIRS, Age, Pleural Effusion), Neutrophil to Lymphocyte (NLR) ratio, Platelet to Lymphocyte Ratio (PLR) ratio. 
February 2024 to July 2024 
 
Target Sample Size   Total Sample Size="128"
Sample Size from India="128" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/02/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Acute pancreatitis has a significant incidence rate and the prognosis of this condition depends on early identification of severity for initiation of prompt treatment. Hence, this study uses the ratio of Red cell Distribution width to Serum Calcium, to prognosticate the progression of acute pancreatitis based on BISAP scores and NLR, PLR ratios to aid in the same.

The trend of the ratio would be looked at to act as a predictor of  severity and mortality of acute pancreatitis.
 
Close